DURABILITY II is the first controlled study to focus on treating long, complex lesions and to specifically test the performance of a single long stent in the superficial femoral artery. Read more about the DURABILITY II clinical study in these published, peer-reviewed journal articles.
The United States Study for Evaluating Endovascular Treatments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By using the Protégé EverFlex Nitinol Stent System II (DURABILITY II).
Matsumura JS, et al. J Vasc Surg. 2013;58:73-83.e1.
Rocha-Singh KJ, et al. Catheter Cardiovasc Interv. 2015;86:164-170.
Tedros RO, et al. Ann Vasc Surg. 2014;28:1-9.